Search

Your search keyword '"Nerve agent"' showing total 45 results

Search Constraints

Start Over You searched for: Descriptor "Nerve agent" Remove constraint Descriptor: "Nerve agent" Publisher springer nature Remove constraint Publisher: springer nature
45 results on '"Nerve agent"'

Search Results

1. Optimizing Medical Care during a Nerve Agent Mass Casualty Incident Using Computer Simulation.

2. Brominated oxime nucleophiles are efficiently reactivating cholinesterases inhibited by nerve agents.

3. Adsorption behavior of VX nerve agent on X12Y12 nanocages: a density functional theory study.

4. Reduced Graphene Oxide Modified Enzyme Inhibition-Based Biosensor System for Detection of Paraoxon as a Nerve Agent Simulant.

5. Effects of the nerve agent VX on hiPSC-derived motor neurons.

6. Evidence of nerve agent VX exposure in rat plasma by detection of albumin-adducts in vitro and in vivo.

7. Solution-processed wafer-scale nanoassembly of conducting polymers enables selective ultratrace nerve agent detection at low power.

8. Optimizing the Schoenemann Reaction for Colorimetric Assays of VX and GD.

9. Fluorimetric Recognition of Nerve Agent Mimic Diethylchlorophosphate Along with Cu2+/Hg2+ Ions Using Imidazole Possessing Sensor.

10. Fabrication of Fast Response and Recovery NiFeAl3+ Nanocomposite Gas Sensor for Detection of Dimethyl Methyl Phosphonate.

12. Unambiguous identification and determination of A234-Novichok nerve agent biomarkers in biological fluids using GC–MS/MS and LC–MS/MS.

13. Catalytic activity and stereoselectivity of engineered phosphotriesterases towards structurally different nerve agents in vitro.

14. A dual-channel optical chemical sensing system for selective detection of nerve agent simulant DFP.

15. Hydrolysis versus aminolysis of a potential nerve agent tabun: a computational reaction mechanism study.

16. A review on analysis methods for nerve agent hydrolysis products.

17. Toward the chemical agent monitor: technologies and developments in England and the United States from 1965 to 1982.

18. In Vivo Evaluation of A1 Adenosine Agonists as Novel Anticonvulsant Medical Countermeasures to Nerve Agent Intoxication in a Rat Soman Seizure Model.

19. Oxime K203: a drug candidate for the treatment of tabun intoxication.

20. Experimental hydrophilic reactivator: bisoxime with three positive charges.

21. Bioanalytical verification of V-type nerve agent exposure: simultaneous detection of phosphonylated tyrosines and cysteine-containing disulfide-adducts derived from human albumin.

22. Fatal sarin poisoning in Syria 2013: forensic verification within an international laboratory network.

23. Time Course, Behavioral Safety, and Protective Efficacy of Centrally Active Reversible Acetylcholinesterase Inhibitors in Cynomolgus Macaques.

24. Pseudocatalytic scavenging of the nerve agent VX with human blood components and the oximes obidoxime and HI-6.

25. Structural Studies on Acetylcholinesterase and Paraoxonase Directed Towards Development of Therapeutic Biomolecules for the Treatment of Degenerative Diseases and Protection Against Chemical Threat Agents.

26. Rapid screening and determination of nerve agent metabolites in human urine by LC-MS/MS.

27. Determination of nerve agent metabolites in human urine by isotope-dilution gas chromatography-tandem mass spectrometry after solid phase supported derivatization.

28. Lab-on-a-chip for rapid electrochemical detection of nerve agent Sarin.

29. In vitro kinetics of nerve agent degradation by fresh frozen plasma (FFP).

30. Toxicogenomic Studies of Human Neural Cells Following Exposure to Organophosphorus Chemical Warfare Nerve Agent VX.

31. Biological markers of exposure to organophosphorus nerve agents.

32. Reactivation kinetics of a homologous series of bispyridinium bis-oximes with nerve agent-inhibited human acetylcholinesterase.

33. Solvolysis process of organophosphorus compound P-[2-(dimethylamino)ethyl]- N, N-dimethylphosphonamidic fluoride with simple and α-nucleophiles: a DFT study.

34. Time-Course Changes of Acetylcholinesterase Activity in Blood and Some Tissues in Rats After Intoxication by Russian VX.

35. Proposal for selective differentiating of nerve agent G and V type with utilisation of modified Ellman’s method.

36. Cerebral acetylcholine and choline contents and turnover following low-dose acetylcholinesterase inhibitors treatment in rats.

37. Microsynthesis and electron ionisation mass spectrometric analysis of chemical weapons convention (CWC)-relatedO,O-dialkyl-N,N-dialkylphosphoramidates.

38. Quantum mechanics and mixed quantum mechanics/molecular mechanics simulations of model nerve agents with acetylcholinesterase.

39. Comparative evaluation of benzodiazepines for control of soman-induced seizures.

40. Relationship between pupil size and acetylcholinesterase activity in patients exposed to sarin vapor.

42. Direct reaction of oximes with crotylsarin, cyclosarin, or VX in vitro

43. Resveratrol fails to provide prophylactic protection in a rat model of organophosphate poisoning

44. Neuregulin-1 inhibits neuroinflammatory responses in a rat model of organophosphate-nerve agent-induced delayed neuronal injury

45. Stability monitoring of some acetylcholinesterase reactivating drugs

Catalog

Books, media, physical & digital resources